Dysregulated TGF-β signaling has also been implicated in many different forms of WHO Group 1 PAH, including heritable disease (resulting from mutations in the TGF-β signaling family, mostly commonly BMPR2), idiopathic, and auto-immune disease triggered PAH. This evidence concerns the gene TGFB1 and pulmonary arterial hypertension.